Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Recursion Pharmaceuticals Inc., 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Recursion Pharmaceuticals Inc. June 17, 202688.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 8, 2026 | Recursion Pharmaceuticals Inc. | Open-market sale | −22,408 | $3.52 | $78,876 |
| Aug 17, 2026 | Recursion Pharmaceuticals Inc. | Shares withheld for tax | −80,498 | $3.16 | $254,374 |
| Jun 5, 2026 | Recursion Pharmaceuticals Inc. | Open-market sale | −23,588 | $3.58 | $84,445 |
| May 15, 2026 | Recursion Pharmaceuticals Inc. | Shares withheld for tax | −62,701 | $3.04 | $190,611 |
| Mar 9, 2026 | Recursion Pharmaceuticals Inc. | Open-market sale | −28,298 | $3.35 | $94,798 |
| Feb 17, 2026 | Recursion Pharmaceuticals Inc. | Shares withheld for tax | −14,280 | $3.49 | $49,837 |
| Feb 6, 2026 | Recursion Pharmaceuticals Inc. | Grant or award | +1,673,546 | — | — |
| Feb 6, 2026 | Recursion Pharmaceuticals Inc. | Grant or award | +30,346 | — | — |
| Feb 6, 2026 | Recursion Pharmaceuticals Inc. | Shares withheld for tax | −10,364 | $3.98 | $41,249 |
| Dec 22, 2025 | Recursion Pharmaceuticals Inc. | Open-market sale | −124,403 | $4.41 | $548,617 |
| Nov 17, 2025 | Recursion Pharmaceuticals Inc. | Shares withheld for tax | −17,584 | $4.14 | $72,798 |
| Nov 5, 2025 | Recursion Pharmaceuticals Inc. | Grant or award | +84,925 | — | — |
| Aug 18, 2025 | Recursion Pharmaceuticals Inc. | Open-market sale | −36,599 | $5.52 | $202,026 |
| Aug 15, 2025 | Recursion Pharmaceuticals Inc. | Shares withheld for tax | −3,789 | $5.64 | $21,370 |
| May 15, 2025 | Recursion Pharmaceuticals Inc. | Shares withheld for tax | −3,796 | $4.25 | $16,133 |
Questions about Najat Khan
What boards is Najat Khan on?
Najat Khan sits on the board of Recursion Pharmaceuticals Inc.
What company is Najat Khan the CEO of?
Najat Khan is CEO and President of Recursion Pharmaceuticals Inc.
How long has Najat Khan served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.